Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CTAS | Common Stock | Options Exercise | $1.07M | +9.9K | +8.66% | $108.39* | 124K | Oct 12, 2021 | Direct | |
transaction | CTAS | Common Stock | Options Exercise | $1.43M | +10.4K | +8.4% | $137.30 | 135K | Oct 12, 2021 | Direct | |
transaction | CTAS | Common Stock | Options Exercise | $1.84M | +8.88K | +6.6% | $206.99 | 144K | Oct 12, 2021 | Direct | |
transaction | CTAS | Common Stock | Options Exercise | $561K | +2.75K | +1.91% | $204.48 | 146K | Oct 12, 2021 | Direct | |
transaction | CTAS | Common Stock | Sale | -$7.47M | -18.5K | -12.64% | $403.84 | 128K | Oct 12, 2021 | Direct | F1 |
transaction | CTAS | Common Stock | Sale | -$1.08M | -2.67K | -2.09% | $405.01 | 125K | Oct 12, 2021 | Direct | F2 |
holding | CTAS | Common Stock | 42.9K | Oct 12, 2021 | By GRAT II 2020 Trust | F3 | |||||
holding | CTAS | Common Stock | 850 | Oct 12, 2021 | By 401(k) Plan |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CTAS | Stock Option (Right to Buy) | Options Exercise | $0 | -9.9K | -100% | $0.00* | 0 | Oct 12, 2021 | Common Stock | 9.9K | $108.39 | Direct | F4 |
transaction | CTAS | Stock Option (Right to Buy) | Options Exercise | $0 | -10.4K | -50% | $0.00 | 10.4K | Oct 12, 2021 | Common Stock | 10.4K | $137.30 | Direct | F4 |
transaction | CTAS | Stock Option (Right to Buy) | Options Exercise | $0 | -8.88K | -33.33% | $0.00 | 17.8K | Oct 12, 2021 | Common Stock | 8.88K | $206.99 | Direct | F4 |
transaction | CTAS | Stock Option (Right to Buy) | Options Exercise | $0 | -2.75K | -33.33% | $0.00 | 5.49K | Oct 12, 2021 | Common Stock | 2.75K | $204.48 | Direct | F4 |
Id | Content |
---|---|
F1 | The Reported Price is a weighted price. These shares were sold in multiple transactions ranging from $403.40 to $404.35. The Reporting Person undertakes to provide full pricing information to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
F2 | The Reported Price is a weighted price. These shares were sold in multiple transactions ranging from $404.46 to $405.33. The Reporting Person undertakes to provide full pricing information to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
F3 | Shares of the Issuer's common stock previously reported as owned indirectly through "GRAT II Trust" are no longer reported as beneficially owned due to the previous maturation of such GRAT and resulting exempt distributions regarding remainder interests. The Reporting Person's direct holdings have also been adjusted to account for reconciliation to the Reporting Person's account records and exempt GRAT distributions. |
F4 | The options vest as follows: one-third on the third anniversary of the grant date, one-third on the fourth anniversary of the grant date, and one-third on the fifth anniversary of the grant date. |